[go: up one dir, main page]

CO2017006496A2 - Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva - Google Patents

Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva

Info

Publication number
CO2017006496A2
CO2017006496A2 CONC2017/0006496A CO2017006496A CO2017006496A2 CO 2017006496 A2 CO2017006496 A2 CO 2017006496A2 CO 2017006496 A CO2017006496 A CO 2017006496A CO 2017006496 A2 CO2017006496 A2 CO 2017006496A2
Authority
CO
Colombia
Prior art keywords
enteroinvasive
coli
bacteriophage
esc
cop
Prior art date
Application number
CONC2017/0006496A
Other languages
English (en)
Inventor
Seong Jun Yoon
Sang Hyeon Kang
Soo Youn Jun
Jee Soo Son
Hyoun Rok Paik
Byung Kuk Kim
Hee Jeong Shin
Dong Min Kang
Original Assignee
Intron Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intron Biotechnology Inc filed Critical Intron Biotechnology Inc
Publication of CO2017006496A2 publication Critical patent/CO2017006496A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B70/00—Preservation of non-alcoholic beverages
    • A23B70/10—Preservation of non-alcoholic beverages by addition of preservatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00—Biological treatment of water, waste water, or sewage
    • C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00—Specific treatment goals
    • C02F2303/04—Disinfection
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2305/00—Use of specific compounds during water treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10131—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Environmental & Geological Engineering (AREA)
  • Hydrology & Water Resources (AREA)
  • Biodiversity & Conservation Biology (AREA)

Abstract

La presente invención se refiere a un bacteriófago aislado de la naturaleza que infecta y destruye E. coli enteroinvasiva, y un método para prevenir y tratar las infecciones de E. coli enteroinvasiva mediante el uso de una composición que comprende el bacteriófago como un ingrediente activo. Más particularmente, la presente invención se refiere a un bacteriófago Myoviridae Esc-COP-4 que se aísla de la naturaleza y puede destruir específicamente cepas de E. coli enteroinvasiva, el cual tiene un genoma representado por la secuencia de nucleótidos de la sec. con núm. de ident.: 1 (número de registro en el KCTC 12663BP), y un método para prevenir las infecciones de E. coli enteroinvasiva y después de eso tratar mediante el uso de la composición que comprende dicho bacteriófago como un ingrediente activo.
CONC2017/0006496A 2014-12-30 2017-06-27 Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva CO2017006496A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140192984A KR101761581B1 (ko) 2014-12-30 2014-12-30 신규한 장침입성 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-4 및 이의 장침입성 대장균 증식 억제 용도
PCT/KR2015/014332 WO2016108542A1 (ko) 2014-12-30 2015-12-28 신규한 장침입성 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-4 및 이의 장침입성 대장균 증식 억제 용도

Publications (1)

Publication Number Publication Date
CO2017006496A2 true CO2017006496A2 (es) 2017-09-20

Family

ID=56284614

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0006496A CO2017006496A2 (es) 2014-12-30 2017-06-27 Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva

Country Status (8)

Country Link
US (1) US10265356B2 (es)
KR (1) KR101761581B1 (es)
CN (1) CN107208067B (es)
BR (1) BR112017013245A2 (es)
CO (1) CO2017006496A2 (es)
MX (1) MX383530B (es)
RU (1) RU2662984C1 (es)
WO (1) WO2016108542A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101761573B1 (ko) * 2014-12-29 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장출혈성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-1 및 이의 장출혈성 대장균 증식 억제 용도
KR101761578B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장병원성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-2 및 이의 장병원성 대장균 증식 억제 용도
KR101761581B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장침입성 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-4 및 이의 장침입성 대장균 증식 억제 용도
KR101649851B1 (ko) * 2014-12-30 2016-08-30 주식회사 인트론바이오테크놀로지 신규한 시가독소생산 F18형 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도
US11058131B2 (en) 2015-04-16 2021-07-13 Kennesaw State University Research And Service Foundation, Inc. Escherichia coli O157:H7 bacteriophage Φ241
KR20180061774A (ko) * 2016-11-30 2018-06-08 주식회사 인트론바이오테크놀로지 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-7 및 이의 병원성 대장균 증식 억제 용도
KR102073094B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-3 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
US11583565B2 (en) * 2020-04-04 2023-02-21 Intron Biotechnology, Inc. Compositions and methods for inhibiting the proliferation of pathogenic Escherichia coli

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002366854A1 (en) * 2001-12-13 2003-07-09 Societe Des Produits Nestle S.A. Isolated phages and their use in food or pet food products
KR100781669B1 (ko) 2006-06-20 2007-12-03 주식회사 인트론바이오테크놀로지 황색포도상구균 특이적 사멸능을 갖는 박테리오파지
RU2531343C2 (ru) 2007-03-02 2014-10-20 ДюПон Ньютришн Байосайенсиз АпС, Способ генерирования заквасочной культуры, заквасочная культура и способ ферментации с ее использованием
KR101016918B1 (ko) 2009-01-08 2011-02-25 주식회사 인트론바이오테크놀로지 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질
US8846368B2 (en) * 2009-09-03 2014-09-30 Cj Cheiljedang Corporation Bacteriophage and antibacterial composition comprising the same
KR101101376B1 (ko) * 2009-10-16 2012-01-02 경희대학교 산학협력단 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지
KR101275263B1 (ko) * 2011-04-01 2013-06-14 서울대학교산학협력단 조류 병원성 대장균 특이 박테리오파지 및 이를 포함하는 항균 조성물
US20130011369A1 (en) 2011-07-05 2013-01-10 Intron Biotechnology, Inc. Method for Prevention and Treatment of Salmonella Infection
KR101260645B1 (ko) * 2011-11-14 2013-05-03 씨제이제일제당 (주) 대장균 특이적 사멸능을 나타내는 신규 분리된 박테리오파지 및 이를 포함하는 항균 조성물
US9504721B2 (en) 2012-06-04 2016-11-29 Ctc Bio, Inc. Bacteriophage and its use for preventing proliferation of pathogenic bacteria
KR101509186B1 (ko) * 2013-05-29 2015-04-08 서울여자대학교 산학협력단 위치정보기반의 가상요금소 설정 및 통행료 지불 시스템 및 그 방법
KR20140140698A (ko) 2013-05-30 2014-12-10 한국외국어대학교 연구산학협력단 에세리키아 콜라이의 박테리오파아지 및 그 용도
KR101581654B1 (ko) 2013-06-27 2015-12-31 주식회사 인트론바이오테크놀로지 K99형 대장균 감염을 방지 및 처치하는 방법
KR101590108B1 (ko) * 2014-04-10 2016-01-29 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
KR101591795B1 (ko) * 2014-04-15 2016-02-04 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
KR101591793B1 (ko) * 2014-04-15 2016-02-04 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
KR101592177B1 (ko) * 2014-05-07 2016-02-05 주식회사 인트론바이오테크놀로지 대장균에 대한 광범위 항균 활성을 갖는 박테리오파지를 활용한 대장균 감염을 방지 및 처치하는 방법
KR101761573B1 (ko) * 2014-12-29 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장출혈성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-1 및 이의 장출혈성 대장균 증식 억제 용도
KR101649849B1 (ko) * 2014-12-29 2016-08-22 주식회사 인트론바이오테크놀로지 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Ｃｌｏ-ＰＥＰ-1 및 이의 클로스트리디움 퍼프린젠스 증식 억제 용도
KR101649851B1 (ko) * 2014-12-30 2016-08-30 주식회사 인트론바이오테크놀로지 신규한 시가독소생산 F18형 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도
KR101761581B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장침입성 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-4 및 이의 장침입성 대장균 증식 억제 용도
KR101761578B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장병원성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-2 및 이의 장병원성 대장균 증식 억제 용도
KR101676621B1 (ko) * 2015-01-16 2016-11-16 주식회사 인트론바이오테크놀로지 신규한 락토코커스 가르비에 박테리오파지 Ｌａｃ-ＧＡＰ-1 및 이의 락토코커스 가르비에 균 증식 억제 용도
KR101679548B1 (ko) 2015-01-28 2016-12-06 주식회사 인트론바이오테크놀로지 신규한 락토바실러스 브레비스 박테리오파지 Ｌａｃ-ＢＲＰ-1 및 이의 락토바실러스 브레비스 균 증식 억제 용도
KR101679549B1 (ko) 2015-01-29 2016-12-06 주식회사 인트론바이오테크놀로지 신규한 락토바실러스 플랜타룸 박테리오파지 Ｌａｃ-ＰＬＰ-1 및 이의 락토바실러스 플랜타룸 균 증식 억제 용도
KR101699245B1 (ko) * 2015-12-21 2017-02-13 주식회사 인트론바이오테크놀로지 신규한 파스튜렐라 멀토시다 박테리오파지 Ｐａｓ-ＭＵＰ-1 및 이의 파스튜렐라 멀토시다 균 증식 억제 용도
EP3474872A4 (en) * 2016-06-22 2019-11-20 The United States Of America As Represented By The Secretary Of The Navy BACTERIOPHAGE COMPOSITIONS AND METHOD FOR SELECTING COMPONENTS AGAINST SPECIFIC BACTERIA
KR20180061774A (ko) * 2016-11-30 2018-06-08 주식회사 인트론바이오테크놀로지 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-7 및 이의 병원성 대장균 증식 억제 용도

Also Published As

Publication number Publication date
US10265356B2 (en) 2019-04-23
KR20160080577A (ko) 2016-07-08
US20170333499A1 (en) 2017-11-23
CN107208067A (zh) 2017-09-26
MX383530B (es) 2025-03-12
BR112017013245A2 (pt) 2018-08-07
RU2662984C1 (ru) 2018-07-31
MX2017008562A (es) 2017-10-26
KR101761581B1 (ko) 2017-07-26
WO2016108542A1 (ko) 2016-07-07
CN107208067B (zh) 2020-09-11

Similar Documents

Publication Publication Date Title
CO2017006494A2 (es) Bacteriófago clo-pep-1 de clostridium perfringens para inhibir la proliferación de clostridium perfringens
CO2017006496A2 (es) Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva
CO2017006495A2 (es) Bacteriófago esc-cop-1 de e. coli tipo f18 productora de toxina shiga para inhibir la proliferación de e. coli tipo f18 productora de toxina shiga
CO2018006947A2 (es) Novedoso bacteriófago pas-mup-1 de pasteurella multocida y su uso para inhibir la proliferación de pasteurella multocida
MX2023013140A (es) Vacunas contra el virus de la hepatitis b.
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
MX2022000453A (es) Compuestos útiles para tratar infecciones por virus de influenza.
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
PH12016502564A1 (en) Substituted nucleosides, nucleosides and analogs thereof
MX2018010680A (es) Composiciones que comprenden cepas bacterianas.
CO2019010062A2 (es) Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens
PH12016502001A1 (en) Novel bacteriophage and composition comprising same
MX389999B (es) Estabilizadores de mastocitos para el tratamiento de hipercitoquinemia e infeccion viral
BR112016024096A2 (pt) novo bacteriófago e composição compreendendo o mesmo
PH12016501999A1 (en) Novel bacteriophage and composition containing same
MX380393B (es) Vectores atenuados de influenza para la prevencion y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncologicas.
PH12016502003A1 (en) Novel bacteriophage and composition containing same
BR112018069974A2 (pt) compostos de tiazolida para o tratamento de infecções virais
CR20160178A (es) Derivados de desoxinojirimicina y sus métodos de uso
CL2017000151A1 (es) Derivados de piridona
MX2018015720A (es) Planta transgenica que tiene resistencia a herbicidas.
CO2020010533A2 (es) Novedoso bacteriófago de salmonella heidelberg sal-hep-1 y su uso para inhibir el crecimiento de las bacterias de salmonella heidelberg
MX381255B (es) Vacunas contra el reovirus aviar.
PH12016502000A1 (en) Novel bacteriophage and composition comprising same